Medicine and Dentistry
Surgery
100%
Glioblastoma
100%
Bevacizumab
100%
Elderly Patient
85%
Overall Survival
57%
Neoplasm
42%
Hazard Ratio
42%
Karnofsky Performance Status
42%
Irinotecan
28%
Chemotherapy
28%
Radiation Therapy
14%
Neurologic Disease
14%
Prognostic Factor
14%
Patient Population
14%
Temporal Lobe
14%
Temozolomide
14%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Bevacizumab
100%
Overall Survival
57%
Neoplasm
42%
Irinotecan
28%
Comorbidity
14%
Neurologic Disease
14%
Temozolomide
14%
Neuroscience
Bevacizumab
100%
Irinotecan
28%
Temporal Lobe
14%
Radiation Therapy
14%
Temozolomide
14%
Keyphrases
Modern Therapy
100%
Maximal Resection
14%
Stepwise Analysis
14%